<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/951E6878-2797-4CF8-958C-D27AB6E74FFD"><gtr:id>951E6878-2797-4CF8-958C-D27AB6E74FFD</gtr:id><gtr:name>University of Nevada</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Inst of Molecular &amp; Cellular Biology</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/951E6878-2797-4CF8-958C-D27AB6E74FFD"><gtr:id>951E6878-2797-4CF8-958C-D27AB6E74FFD</gtr:id><gtr:name>University of Nevada</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D8B5C3A3-7A27-42A5-8B56-24B03FB5BF72"><gtr:id>D8B5C3A3-7A27-42A5-8B56-24B03FB5BF72</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>D.</gtr:otherNames><gtr:surname>Harvey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3935C0BF-6774-4347-9AA3-792DDEB15008"><gtr:id>3935C0BF-6774-4347-9AA3-792DDEB15008</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Colyer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C180AFC0-A799-434B-9FE1-436F3FFF4524"><gtr:id>C180AFC0-A799-434B-9FE1-436F3FFF4524</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:surname>Calaghan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700889"><gtr:id>70E057E0-1711-4A02-8DF3-EF93B6DC6EC3</gtr:id><gtr:title>The role of caveolae in generating receptor-specific cyclic AMP signals in the adult cardiac myocyte</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700889</gtr:grantReference><gtr:abstractText>The ability of the heart to pump blood is increased by stimulation of beta receptors in the membrane of the heart muscle cell, for example, during exercise. These effects are opposed by another type of receptor, the muscarinic receptor. When these receptors are stimulated, a chain of events is initiated which leads to changes in electrical activity across the membrane, in the movement of calcium around the cell, and to interaction of contractile elements. All these processes combine to produce the ultimate effect of receptor stimulation on the heart cell - a change in the rate or force of beating. What is interesting is that although different receptors have different effects on the cell, they often share a common signaling molecule. Beta and muscarinic receptors both use a small molecule called cyclic AMP (cAMP). We know that for each receptor to achieve its typical response through cAMP, the changes in cAMP within the cell must be receptor-specific in terms of duration, size and location. We think that caveolae, which are small flask-like pits in the cell membrane, play an important role in shaping the characteristics of the cAMP signal. Caveolae can act as a compartment which brings together (and regulates) proteins which produce, or breakdown, cAMP. We have already shown for the first time that when caveolae are removed from the cell membrane, the beating response of the cardiac cell to stimulation of a subtype of beta receptor (beta2) and muscarinic receptor (M2) are affected. We want to understand how caveolae exert their influence on cAMP control in the cell. Our team, which consists of researchers in the UK and the USA, represents a unique combination of expertise which will allow us to describe in detail the characteristics of signals arising from beta2 and M2 receptor stimulation, and how these translate into functional effects on the cell. We can show whether proteins which regulate cAMP levels are enriched in the caveolar portion of the membrane. By manipulating caveolae and by using drugs to affect the different parts of the cAMP cascade, this study will allow us to show how caveolae shape cAMP signals. Because caveolae are found in almost all cells of the body, it is vital that we understand how they can affect cellular signaling. This work also has profound implications for many diseases (including heart diseases) which are associated with changes in the number or function of caveolae.</gtr:abstractText><gtr:technicalSummary>How does biology achieve such a diversity of cellular responses with its finite pool of second messengers? In cardiac myocytes, cyclic AMP is the most important second messenger for regulation of the strength, frequency and time-course of contraction. A variety of G-protein coupled receptors, including beta-adrenoceptors and muscarinic receptors, signal through cyclic AMP. Our recent data show evidence that caveolae, small flask-like invaginations of the cell membrane, play a vital role in generating receptor specific cAMP-dependent signals in the adult cardiac myocyte. We suggest that this is achieved by temporal and spatial control of cAMP through formation of specific signaling complexes in these microdomains which facilitate communication between two receptors (beta2 adrenoceptors and muscarinic M2) and their downstream Gi partners. In this study we will establish how caveolae exert their influence on cAMP-dependent signaling. We will define the signature of signals arising from stimulation of beta2 and M2 receptors by assessing the spatial and temporal characteristics of changes in cAMP (using FRET-based biosensors based on protein kinase A and Epac which index membrane and cytosolic cAMP respectively), and the pattern and extent of site-specific phosphorylation of key proteins. The integration of these signals into functional consequences will be measured at the cellular level in terms of electrical activity (ICa,L), [Ca2+]i and contraction. Using sucrose density gradient fractionation, co-immunoprecipitation and electron microscopy, we will establish whether cascade components are located in caveolae and if they interact with caveolin 3. By manipulating components of the signal cascades and caveolae we will determine at what level caveolae regulate Gi-dependent signaling. The focus of our attention will be restriction of the beta2-stimulated cAMP signal to the sarcolemma via PI3 kinase and phosphodiesterase (PDE), and caveolar regulation of the facilitatory cAMP response to M2 stimulation by stimulation of adenyl cyclase 4/7 or inhibition of PDE 3 through nitric oxide. This study will lead to the development of the first dynamic molecular model of caveolar control of cAMP signaling through Gi in the adult cardiac myocyte. Because caveolae are found in almost all differentiated cells, this work will provide essential insight into strategies used by cells to define receptor-specific signals. We predict that it will have profound implications for many diseases which are associated with changes in caveolae.</gtr:technicalSummary><gtr:fund><gtr:end>2011-01-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-31</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>273708</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nevada</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Harvey</gtr:description><gtr:id>D604E987-44E9-4ACD-A122-6FED433EEC8C</gtr:id><gtr:impact>21782827
21740911
21115018</gtr:impact><gtr:outcomeId>p1Q2jahSw9N-1</gtr:outcomeId><gtr:partnerContribution>Experimental data. Co-wrote research and review articles</gtr:partnerContribution><gtr:piContribution>Wrote grant application for funding of collaborative work - included funds for salary for US based PDRA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>16532</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Biomedical Health Research Centre (BHRC)</gtr:department><gtr:description>Problem Solving Fund</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>University of Leeds</gtr:fundingOrg><gtr:id>1DD670B5-95A5-4202-9EE7-7206DF7A290E</gtr:id><gtr:outcomeId>pXzG8sAbjS6</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CB1BDD59-1021-48B2-9828-C55E9B37C6C1</gtr:id><gtr:title>Caveolae as key regulators of cardiac myocyte ?2 adrenoceptor signalling: a novel target for statins.</gtr:title><gtr:parentPublicationTitle>Proc Physiol Soc</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e058a0a0918796fedc63bc2754782bd0"><gtr:id>e058a0a0918796fedc63bc2754782bd0</gtr:id><gtr:otherNames>Calaghan, Sarah</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>tGVPG7skHpR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D705D6AE-EF53-4EA9-AB40-6CDC8037BD45</gtr:id><gtr:title>Local signalling in myocytes.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/407d65dc07f5aa768207a8d2e93ca17a"><gtr:id>407d65dc07f5aa768207a8d2e93ca17a</gtr:id><gtr:otherNames>Calaghan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>pm_13069_29_22064326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>505B06D4-9A2F-459A-A8F0-C32FDAA33DB8</gtr:id><gtr:title>Caveolae compartmentalise ?2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b20027cbfc139637a18812e3676855d"><gtr:id>7b20027cbfc139637a18812e3676855d</gtr:id><gtr:otherNames>Macdougall DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>eeL9ZYDq5yi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABEFF1A9-396D-4D3B-9DE9-077B0624554D</gtr:id><gtr:title>Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f71bcc81aecc8f2f12b27d5489b46de"><gtr:id>3f71bcc81aecc8f2f12b27d5489b46de</gtr:id><gtr:otherNames>Agarwal SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>Epeim6FT9WS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>124AB539-2700-44E6-A46F-E7E3B1A297A7</gtr:id><gtr:title>Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a1ddbd18069ccb640304ad737645392"><gtr:id>0a1ddbd18069ccb640304ad737645392</gtr:id><gtr:otherNames>Harvey RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>pm_13069_29_21782827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>980401C7-D6EB-40EF-A34D-1E2B80E61435</gtr:id><gtr:title>Caveolae limit ?2-adrenoceptor-derived cAMP signals in the adult cardiac myocyte</gtr:title><gtr:parentPublicationTitle>Proc Physiol Soc</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fc412eafd189851eb90414c37d0f86f"><gtr:id>6fc412eafd189851eb90414c37d0f86f</gtr:id><gtr:otherNames>MacDougall, David</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>U6bdVoAbtkK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C2374D-B56E-454C-A131-2CC28F81A5D7</gtr:id><gtr:title>Caveolae contribute to spatial control of cAMP within the cardiac cell</gtr:title><gtr:parentPublicationTitle>IUPS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8d903a168b3f8faeb51332868817bd7"><gtr:id>b8d903a168b3f8faeb51332868817bd7</gtr:id><gtr:otherNames>Calaghan</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>R63SCC983W5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1433B02-AE70-422A-B1AA-3F579C06845F</gtr:id><gtr:title>Caveolar compartmentation of beta2-adrenoceptor cAMP signalling in the adult cardiac myocyte depends on protein phosphatases, but not phosphodiesterases or phosphoinositide-3-kinase</gtr:title><gtr:parentPublicationTitle>FEBS JOURNAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/075a5ee6063eb0987e1016c473cbd295"><gtr:id>075a5ee6063eb0987e1016c473cbd295</gtr:id><gtr:otherNames>MacDougall D. A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>Rbwy3AMW5A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47432B62-3D33-4E0F-882F-1045FDDEC009</gtr:id><gtr:title>Caveolae selectively control cAMP-dependent signalling in a compartment containing phospholamban following _2 adrenoceptor stimulation in the adult rat cardiac myocyte</gtr:title><gtr:parentPublicationTitle>Proc Physiol Soc</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fc412eafd189851eb90414c37d0f86f"><gtr:id>6fc412eafd189851eb90414c37d0f86f</gtr:id><gtr:otherNames>MacDougall, David</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>SHaBxo1rRB3</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700889</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>